{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:43:00Z","timestamp":1793032980326,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Hebei Medical Science Research Project","award":["20221114"],"award-info":[{"award-number":["20221114"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-025-01819-x","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T10:31:54Z","timestamp":1752834714000},"page":"4989-5001","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["PCBP2 Promotes NRG4 mRNA Stability to Diminish Angiotensin II-Induced Hypertrophy, NLRP3 Inflammasome Activation, and Oxidative Stress of AC16 Cardiomyocytes"],"prefix":"10.1007","volume":"83","author":[{"given":"Yang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"issue":"13","key":"1819_CR1","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.3390\/cells12131780","volume":"12","author":"F Bazgir","year":"2023","unstructured":"Bazgir, F., Nau, J., Nakhaei-Rad, S., Amin, E., Wolf, M. J., Saucerman, J. J., Lorenz, K., & Ahmadian, M. R. (2023). The microenvironment of the pathogenesis of cardiac hypertrophy. Cells, 12(13), 1780 https:\/\/doi.org\/10.3390\/cells12131780.","journal-title":"Cells"},{"issue":"2","key":"1819_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1161\/circresaha.119.316358","volume":"126","author":"TR Matsuura","year":"2020","unstructured":"Matsuura, T. R., Leone, T. C., & Kelly, D. P. (2020). Fueling cardiac hypertrophy. Circulation Research, 126(2), 197\u2013199. https:\/\/doi.org\/10.1161\/circresaha.119.316358.","journal-title":"Circulation Research"},{"issue":"7","key":"1819_CR3","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.3390\/ijms23073587","volume":"23","author":"K Nakamura","year":"2022","unstructured":"Nakamura, K., Miyoshi, T., Yoshida, M., Akagi, S., Saito, Y., Ejiri, K., Matsuo, N., Ichikawa, K., Iwasaki, K., Naito, T., Namba, Y., Yoshida, M., Sugiyama, H., & Ito, H. (2022). Pathophysiology and treatment of diabetic cardiomyopathy and heart failure in patients with diabetes mellitus. International Journal of Molecular Sciences, 23(7), 3587 https:\/\/doi.org\/10.3390\/ijms23073587.","journal-title":"International Journal of Molecular Sciences"},{"key":"1819_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","volume":"41","author":"J Fu","year":"2023","unstructured":"Fu, J., & Wu, H. (2023). Structural mechanisms of NLRP3 inflammasome assembly and activation. Annual Review of Immunology, 41, 301\u2013316. https:\/\/doi.org\/10.1146\/annurev-immunol-081022-021207.","journal-title":"Annual Review of Immunology"},{"issue":"5","key":"1819_CR5","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41590-021-00886-5","volume":"22","author":"BR Sharma","year":"2021","unstructured":"Sharma, B. R., & Kanneganti, T. D. (2021). NLRP3 inflammasome in cancer and metabolic diseases. Nature Immunology, 22(5), 550\u2013559. https:\/\/doi.org\/10.1038\/s41590-021-00886-5.","journal-title":"Nature Immunology"},{"key":"1819_CR6","doi-asserted-by":"publisher","first-page":"108053","DOI":"10.1016\/j.pharmthera.2021.108053","volume":"236","author":"S Toldo","year":"2022","unstructured":"Toldo, S., Mezzaroma, E., Buckley, L. F., Potere, N., Di Nisio, M., Biondi-Zoccai, G., Van Tassell, B. W., & Abbate, A. (2022). Targeting the NLRP3 inflammasome in cardiovascular diseases. Pharmacology & Therapeutics, 236, 108053 https:\/\/doi.org\/10.1016\/j.pharmthera.2021.108053.","journal-title":"Pharmacology & Therapeutics"},{"issue":"12","key":"1819_CR7","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1161\/circulationaha.119.042336","volume":"141","author":"X Tang","year":"2020","unstructured":"Tang, X., Pan, L., Zhao, S., Dai, F., Chao, M., Jiang, H., Li, X., Lin, Z., Huang, Z., Meng, G., Wang, C., Chen, C., Liu, J., Wang, X., Ferro, A., Wang, H., Chen, H., Gao, Y., Lu, Q., Xie, L., Han, Y., & Ji, Y. (2020). SNO-MLP (S-Nitrosylation of muscle LIM protein) facilitates myocardial hypertrophy through TLR3 (Toll-like receptor 3)-mediated RIP3 (Receptor-interacting protein kinase 3) and NLRP3 (NOD-like receptor pyrin domain containing 3) inflammasome activation. Circulation, 141(12), 984\u20131000. https:\/\/doi.org\/10.1161\/circulationaha.119.042336.","journal-title":"Circulation"},{"issue":"4","key":"1819_CR8","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1161\/circulationaha.122.060860","volume":"147","author":"Y Higashikuni","year":"2023","unstructured":"Higashikuni, Y., Liu, W., Numata, G., Tanaka, K., Fukuda, D., Tanaka, Y., Hirata, Y., Imamura, T., Takimoto, E., Komuro, I., & Sata, M. (2023). NLRP3 inflammasome activation through heart-brain interaction initiates cardiac inflammation and hypertrophy during pressure overload. Circulation, 147(4), 338\u2013355. https:\/\/doi.org\/10.1161\/circulationaha.122.060860.","journal-title":"Circulation"},{"issue":"12","key":"1819_CR9","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1038\/nm.3713","volume":"20","author":"GX Wang","year":"2014","unstructured":"Wang, G. X., Zhao, X. Y., Meng, Z. X., Kern, M., Dietrich, A., Chen, Z., Cozacov, Z., Zhou, D., Okunade, A. L., Su, X., Li, S., Bl\u00fcher, M., & Lin, J. D. (2014). The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis. Nature Medicine, 20(12), 1436\u20131443. https:\/\/doi.org\/10.1038\/nm.3713.","journal-title":"Nature Medicine"},{"key":"1819_CR10","doi-asserted-by":"publisher","first-page":"116327","DOI":"10.1016\/j.bcp.2024.116327","volume":"225","author":"L Chen","year":"2024","unstructured":"Chen, L., Xuan, Y., Zhu, Y., Wang, J., Tian, W., Yang, X., Chen, W., Chen, S., Wang, S., Miao, Q., Liu, Y., Zhang, R., Hu, C., Zhang, Y., Jin, L., & Yu, H. (2024). Adipocyte secreted NRG4 ameliorates age-associated metabolic dysfunction. Biochemical Pharmacology, 225, 116327 https:\/\/doi.org\/10.1016\/j.bcp.2024.116327.","journal-title":"Biochemical Pharmacology"},{"issue":"11","key":"1819_CR11","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1038\/s42255-022-00671-0","volume":"4","author":"L Shi","year":"2022","unstructured":"Shi, L., Li, Y., Xu, X., Cheng, Y., Meng, B., Xu, J., Xiang, L., Zhang, J., He, K., Tong, J., Zhang, J., Xiang, L., & Xiang, G. (2022). Brown adipose tissue-derived Nrg4 alleviates endothelial inflammation and atherosclerosis in male mice. Nature Metabolism, 4(11), 1573\u20131590. https:\/\/doi.org\/10.1038\/s42255-022-00671-0.","journal-title":"Nature Metabolism"},{"key":"1819_CR12","doi-asserted-by":"publisher","first-page":"156314","DOI":"10.1016\/j.cyto.2023.156314","volume":"170","author":"E Alipoor","year":"2023","unstructured":"Alipoor, E., Hosseinzadeh-Attar, M. J., Vasheghani-Farahani, A., Salmani, M., Rezaei, M., Namkhah, Z., Ahmadpanahi, M., Jenab, Y., Alidoosti, M., & Yaseri, M. (2023). The relationship of circulating neuregulin 4 and irisin, and traditional and novel cardiometabolic risk factors with the risk and severity of coronary artery disease. Cytokine, 170, 156314 https:\/\/doi.org\/10.1016\/j.cyto.2023.156314.","journal-title":"Cytokine"},{"issue":"1","key":"1819_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01643-0","volume":"21","author":"H Wang","year":"2022","unstructured":"Wang, H., Wang, L., Hu, F., Wang, P., Xie, Y., Li, F., & Guo, B. (2022). Neuregulin-4 attenuates diabetic cardiomyopathy by regulating autophagy via the AMPK\/mTOR signalling pathway. Cardiovascular Diabetology, 21(1), 205 https:\/\/doi.org\/10.1186\/s12933-022-01643-0.","journal-title":"Cardiovascular Diabetology"},{"issue":"Pt 2","key":"1819_CR14","doi-asserted-by":"publisher","first-page":"113301","DOI":"10.1016\/j.intimp.2024.113301","volume":"143","author":"H Wei","year":"2024","unstructured":"Wei, H., Guo, X., Yan, J., Tian, X., Yang, W., Cui, K., Wang, L., & Guo, B. (2024). Neuregulin-4 alleviates isoproterenol (ISO)-induced cardial remodeling by inhibiting inflammation and apoptosis via AMPK\/NF-\u03baB pathway. International Immunopharmacology, 143(Pt 2), 113301 https:\/\/doi.org\/10.1016\/j.intimp.2024.113301.","journal-title":"International Immunopharmacology"},{"issue":"1","key":"1819_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-024-00505-x","volume":"19","author":"P Wang","year":"2024","unstructured":"Wang, P., Guo, X., Wang, H., Wang, L., Ma, M., & Guo, B. (2024). Neuregulin-4 protects cardiomyocytes against high-glucose-induced ferroptosis via the AMPK\/NRF2 signalling pathway. Biology Direct, 19(1), 62 https:\/\/doi.org\/10.1186\/s13062-024-00505-x.","journal-title":"Biology Direct"},{"issue":"1","key":"1819_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.14715\/cmb\/2022.68.1.12","volume":"68","author":"Z Yang","year":"2022","unstructured":"Yang, Z., Yaling, W., Tao, L., Mingyue, R., & Yongjun, L. (2022). Cardioprotective effect of NRG-4 gene expression on spontaneous hypertension rats and its mechanism through mediating the activation of ErbB signaling pathway. Cellular and Molecular Biology, 68(1), 89\u2013101. https:\/\/doi.org\/10.14715\/cmb\/2022.68.1.12.","journal-title":"Cellular and Molecular Biology"},{"key":"1819_CR17","doi-asserted-by":"publisher","first-page":"107841","DOI":"10.1016\/j.intimp.2021.107841","volume":"98","author":"B Ren","year":"2021","unstructured":"Ren, B., Feng, J., Yang, N., Guo, Y., Chen, C., & Qin, Q. (2021). Ginsenoside Rg3 attenuates angiotensin II-induced myocardial hypertrophy through repressing NLRP3 inflammasome and oxidative stress via modulating SIRT1\/NF-\u03baB pathway. International Immunopharmacology, 98, 107841 https:\/\/doi.org\/10.1016\/j.intimp.2021.107841.","journal-title":"International Immunopharmacology"},{"issue":"6","key":"1819_CR18","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/cbin.12001","volume":"47","author":"L Yue","year":"2023","unstructured":"Yue, L., Sheng, S., Yuan, M., Lu, J., Li, T., Shi, Y., & Dong, Z. (2023). HypERlnc attenuates angiotensin II-induced cardiomyocyte hypertrophy via promoting SIRT1 SUMOylation-mediated activation of PGC-1\u03b1\/PPAR\u03b1 pathway in AC16 cells. Cell Biology International, 47(6), 1068\u20131080. https:\/\/doi.org\/10.1002\/cbin.12001.","journal-title":"Cell Biology International"},{"issue":"1","key":"1819_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00441-021-03541-5","volume":"387","author":"X Hu","year":"2022","unstructured":"Hu, X., Wu, P., Liu, B., Lang, Y., & Li, T. (2022). RNA-binding protein CELF1 promotes cardiac hypertrophy via interaction with PEBP1 in cardiomyocytes. Cell and Tissue Research, 387(1), 111\u2013121. https:\/\/doi.org\/10.1007\/s00441-021-03541-5.","journal-title":"Cell and Tissue Research"},{"issue":"8","key":"1819_CR20","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1161\/circulationaha.120.051094","volume":"144","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Da, Q., Cao, S., Yan, K., Shi, Z., Miao, Q., Li, C., Hu, L., Sun, S., Wu, W., Wu, L., Chen, F., Wang, L., Gao, Y., Huang, Z., Shao, Y., Chen, H., Wei, Y., Chen, F., Han, Y., Xie, L., & Ji, Y. (2021). HINT1 (Histidine triad nucleotide-binding protein 1) attenuates cardiac hypertrophy via suppressing HOXA5 (homeobox A5) expression. Circulation, 144(8), 638\u2013654. https:\/\/doi.org\/10.1161\/circulationaha.120.051094.","journal-title":"Circulation"},{"issue":"8","key":"1819_CR21","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1080\/10985549.2024.2374083","volume":"44","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y., Shang, Z., Xu, S., Zhou, G., & Liu, A. (2024). ELF5-regulated lncRNA-TTN-AS1 alleviates myocardial cell injury via recruiting PCBP2 to increase CDK6 stability in myocardial infarction. Molecular and Cellular Biology, 44(8), 303\u2013315. https:\/\/doi.org\/10.1080\/10985549.2024.2374083.","journal-title":"Molecular and Cellular Biology"},{"issue":"3","key":"1819_CR22","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.bbrc.2015.06.139","volume":"464","author":"Y Zhang","year":"2015","unstructured":"Zhang, Y., Si, Y., Ma, N., & Mei, J. (2015). The RNA-binding protein PCBP2 inhibits Ang II-induced hypertrophy of cardiomyocytes though promoting GPR56 mRNA degeneration. Biochemical and Biophysical Research Communications, 464(3), 679\u2013684. https:\/\/doi.org\/10.1016\/j.bbrc.2015.06.139.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"1","key":"1819_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/iub.1456","volume":"68","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y., Si, Y., & Ma, N. (2016). Meis1 promotes poly (rC)-binding protein 2 expression and inhibits angiotensin II-induced cardiomyocyte hypertrophy. IUBMB Life, 68(1), 13\u201322. https:\/\/doi.org\/10.1002\/iub.1456.","journal-title":"IUBMB Life"},{"issue":"4","key":"1819_CR24","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.devcel.2023.01.006","volume":"58","author":"YJ Lee","year":"2023","unstructured":"Lee, Y. J., Shin, K. J., Jang, H. J., Ryu, J. S., Lee, C. Y., Yoon, J. H., Seo, J. K., Park, S., Lee, S., Je, A. R., Huh, Y. H., Kong, S. Y., Kwon, T., Suh, P. G., & Chae, Y. C. (2023). GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis. Developmental Cell, 58(4), 320\u201334.e8. https:\/\/doi.org\/10.1016\/j.devcel.2023.01.006.","journal-title":"Developmental Cell"},{"issue":"5","key":"1819_CR25","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41401-020-0496-1","volume":"42","author":"BY Liu","year":"2021","unstructured":"Liu, B. Y., Li, L., Liu, G. L., Ding, W., Chang, W. G., Xu, T., Ji, X. Y., Zheng, X. X., Zhang, J., & Wang, J. X. (2021). Baicalein attenuates cardiac hypertrophy in mice via suppressing oxidative stress and activating autophagy in cardiomyocytes. Acta Pharmacologica Sinica, 42(5), 701\u2013714. https:\/\/doi.org\/10.1038\/s41401-020-0496-1.","journal-title":"Acta Pharmacologica Sinica"},{"issue":"6","key":"1819_CR26","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/cbin.11566","volume":"45","author":"H Liao","year":"2021","unstructured":"Liao, H., Gao, W., Ma, J., Xue, H., Wang, Y., Huang, D., Yan, F., & Ye, Y. (2021). GPR39 promotes cardiac hypertrophy by regulating the AMPK-mTOR pathway and protein synthesis. Cell Biology International, 45(6), 1211\u20131219. https:\/\/doi.org\/10.1002\/cbin.11566.","journal-title":"Cell Biology International"},{"issue":"9","key":"1819_CR27","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1093\/abbs\/gmab099","volume":"53","author":"J Wang","year":"2021","unstructured":"Wang, J., Fan, S., Xiong, Q., Niu, Y., Zhang, X., Qin, J., Shi, Y., & Zhang, L. (2021). Glucagon-like peptide-1 attenuates cardiac hypertrophy via the AngII\/AT1R\/ACE2 and AMPK\/mTOR\/p70S6K pathways. Acta Biochimica et Biophysica Sinica, 53(9), 1189\u20131197. https:\/\/doi.org\/10.1093\/abbs\/gmab099.","journal-title":"Acta Biochimica et Biophysica Sinica"},{"issue":"10","key":"1819_CR28","doi-asserted-by":"publisher","first-page":"e30634","DOI":"10.1002\/jcb.30634","volume":"125","author":"J Deng","year":"2024","unstructured":"Deng, J., Yang, Q., Zhu, W., Zhang, Y., Lin, M., She, J., Li, J., Xiao, Y., Xiao, J., Xu, X., He, H., Zhu, B., & Ding, Y. (2024). Neuregulin 4 attenuates podocyte injury and proteinuria in part by activating AMPK\/mTOR-mediated autophagy in mice. Journal of Cellular Biochemistry, 125(10), e30634 https:\/\/doi.org\/10.1002\/jcb.30634.","journal-title":"Journal of Cellular Biochemistry"},{"key":"1819_CR29","doi-asserted-by":"publisher","first-page":"110844","DOI":"10.1016\/j.cellsig.2023.110844","volume":"110","author":"S Han","year":"2023","unstructured":"Han, S., Jin, X., Hu, T., & Chi, F. (2023). The mRNA stability of NCAPG2, a novel contributor to breast invasive carcinoma, is enhanced by the RNA-binding protein PCBP2. Cellular Signalling, 110, 110844 https:\/\/doi.org\/10.1016\/j.cellsig.2023.110844.","journal-title":"Cellular Signalling"},{"issue":"10","key":"1819_CR30","doi-asserted-by":"publisher","first-page":"7592","DOI":"10.1002\/jcp.29667","volume":"235","author":"D Wen","year":"2020","unstructured":"Wen, D., Huang, Z., Li, Z., Tang, X., Wen, X., Liu, J., & Li, M. (2020). LINC02535 co-functions with PCBP2 to regulate DNA damage repair in cervical cancer by stabilizing RRM1 mRNA. Journal of Cellular Physiology, 235(10), 7592\u20137603. https:\/\/doi.org\/10.1002\/jcp.29667.","journal-title":"Journal of Cellular Physiology"},{"key":"1819_CR31","doi-asserted-by":"publisher","first-page":"155200","DOI":"10.1016\/j.metabol.2022.155200","volume":"131","author":"LS Yan","year":"2022","unstructured":"Yan, L. S., Zhang, S. F., Luo, G., Cheng, B. C., Zhang, C., Wang, Y. W., Qiu, X. Y., Zhou, X. H., Wang, Q. G., Song, X. L., Pan, S. Y., & Zhang, Y. (2022). Schisandrin B mitigates hepatic steatosis and promotes fatty acid oxidation by inducing autophagy through AMPK\/mTOR signaling pathway. Metabolism: Clinical and Experimental, 131, 155200 https:\/\/doi.org\/10.1016\/j.metabol.2022.155200.","journal-title":"Metabolism: Clinical and Experimental"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01819-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-025-01819-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01819-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T04:50:27Z","timestamp":1764910227000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-025-01819-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1819"],"URL":"https:\/\/doi.org\/10.1007\/s12013-025-01819-x","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"23 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Written informed consents were obtained from all participants and this study was permitted by the Ethics Committee of the Second Hospital of Hebei Medical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}}]}}